StockData
Zevra Therapeutics, Inc. logo

Zevra Therapeutics, Inc. (ZVRA) stock

ZVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3060% below fair value
$9.28−0.12 (-1.28%)

Close on Nov 18, 2026Market cap $551.08MP/E 10.0Yield –

Zevra Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Zevra Therapeutics's market cap was $703.20M on Nov 11, 2026, against $473.92M a year earlier. Over the last 5 years it ranged from $152.00M to $847.71M, with a median of $279.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$703.20M+39.6%
2025Dec 31, 2025$503.71M+13.5%
2024Dec 31, 2024$443.92M+87.2%
2023Dec 29, 2023$237.19M+49.8%
2022Dec 30, 2022$158.36M-48.5%
2021Dec 31, 2021$307.61M+506.0%
2020Dec 31, 2020$50.76M+313.2%
2019Dec 31, 2019$12.28M-57.0%
2018Dec 31, 2018$28.55M-51.9%
2017Dec 29, 2017$59.36M+37.4%
2016Dec 30, 2016$43.21M-84.7%
2015Dec 31, 2015$282.84M–

More Zevra Therapeutics figures

See a number that looks wrong?